Transformation from lepromatous to borderline leprosy under clofazimine therapy.
Patients of lepromatous leprosy who have evolved from the borderline type of disease are known to revert to the borderline state through a reactionary phenomenon under anti-leprosy chemotherapy with Dapsone. We present here the case report of a reversal from a reactional lepromatous disease to the borderline type under Clofazimine.
D000328:Adult; D002991:Clofazimine / Q000627:therapeutic use*; D003622:Dapsone / Q000627:therapeutic use; D006801:Humans; D007918:Leprosy / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D008297:Male; D012867:Skin / Q000473:pathology
D003622:Dapsone; D002991:Clofazimine